Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-24-001927
Filing Date
2024-12-23
Accepted
2024-12-23 16:01:12
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4335
  Complete submission text file 0001640334-24-001927.txt   5997
Mailing Address C/O INNOVIVE PHARMACEUTICALS, INC. 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Kelly Steven (Reporting) CIK: 0001339478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38951 | Film No.: 241573512

Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Issuer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)